Clinical development
- Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients
18 Nov, 2024 - A new Israeli clinical trial is testing a tuberculosis vaccine to prevent Alzheimer’s – opinion
18 Nov, 2024 - Safety of simultaneous vs sequential mRNA COVID-19 and inactivated influenza vaccines
18 Nov, 2024 - Early Tenofovir Treatment and Vaccination Effective in Preventing Hepatitis B Transmission
17 Nov, 2024 - Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection
17 Nov, 2024 - Shigellosis Vaccine Enters Critical Testing Phase Amid Global Disease Surge
15 Nov, 2024 - Breast cancer vaccine update from Cleveland Clinic: ‘A new era’
14 Nov, 2024 - Wash U researchers find vaccine that shows promise against aggressive breast cancer
14 Nov, 2024 - Osivax begins phase 2a booster trial for influenza vaccine
14 Nov, 2024 - Vaccine shows promise in curing HIV, Hong Kong biotech start-up says
14 Nov, 2024 - Infinitopes to showcase cancer vaccine progress ahead of 2025 NHS trial
14 Nov, 2024 - Valneva: first vaccination in a trial with S4V
14 Nov, 2024 - Could vaccine for winter vomiting bug be near?
14 Nov, 2024 - Clinical trial to develop mpox vaccine set to begin in Kenya
14 Nov, 2024 - Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2
13 Nov, 2024 - PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGe
13 Nov, 2024 - Cellid finishes phase 3 dosing of Omicron-targeted Covid-19 vaccine
13 Nov, 2024 - Indonesia takes leadership role in tackling TB with development of new vaccine candidates
13 Nov, 2024 - First bivalent mRNA vaccine candidate against RSV goes under clinical trial
13 Nov, 2024 - Stewardship intervention linked to small improvement in asymptomatic bacteriuria treatment
12 Nov, 2024 - Poster Presentation at International mRNA Health Conference Showcases Clinical Evidence that PharmaJet® Delivery Systems Enable mRNA Vaccine Delivery
12 Nov, 2024 - Rebuilding Trust in Intranasal Vaccines for Avian Flu and Other Respiratory Diseases
12 Nov, 2024 - FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
12 Nov, 2024 - Russian anti-tuberculosis vaccine is in the final stage of clinical trials
12 Nov, 2024 - CSPC Pharmaceutical Gains Approval for HPV Vaccine Trials
12 Nov, 2024 - I was diagnosed with colon cancer – but one innovative vaccine has saved my life
12 Nov, 2024 - Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
12 Nov, 2024 - mpox vaccine appears safe and effective in adolescents
11 Nov, 2024 - Arcturus Gets FDA Green Light for H5N1 Flu mRNA Vaccine Trial, Backed by BARDA
11 Nov, 2024
0 Comments